期刊文献+

CTRP3通过调节Sirt1参与高糖条件下肾小管细胞的胆固醇转运 被引量:1

CTRP3 Mediates Cholesterol Transport in Renal Tubular Cells under High Glucose Condition by Regulating Sirt1
原文传递
导出
摘要 该文探究了C1q/肿瘤坏死因子相关蛋白-3(C1q/TNF-related protein 3,CTRP3)在高糖条件下肾小管细胞胆固醇转运中的作用及机制。体外培养人肾小管上皮细胞HK-2,随机分为正常糖对照组(NG)、正常糖+CTRP3干预组(NG+CT)、高糖培养组(HG)、高糖培养+CTRP3干预组(HG+CT)、高糖培养+CTRP3干预组+siRNA转染组(HG+CT+siRNA)和高糖培养+CTRP3干预组+Sirt1 siRNA转染组(HG+CT+siSirt1)。试剂盒检测细胞内胆固醇含量及胆固醇流出情况;Filipin染色观察细胞内胆固醇蓄积情况;试剂盒检测Sirt1酶活性;Western blot检测CTRP3、Sirt1、ABCA1及LXRα的蛋白表达;实时定量PCR检测CTRP3的mRNA表达。结果显示,重组CTRP3蛋白干预能够抑制高糖条件下HK-2细胞胆固醇蓄积,上调ABCA1及LXRα的表达从而促进胆固醇外流;同时增强Sirt1的蛋白表达及活性;应用Sirt1 siRNA抑制Sirt1的表达后CTRP3的上述调控作用均消失了。以上结果提示,CTRP3对高糖条件下的肾小管细胞的保护作用,可能是部分通过调控Sirt1的表达促进高糖条件下肾小管细胞的胆固醇外流实现的。 The purpose of this study is to investigate the role and molecular mechanisms of CTRP3 on cholesterol transport in renal tubular cells under high glucose condition.Cultured HK-2 cells were randomly divided into normal glucose group(NG),NG plus CTRP3 group(NG+CT),high glucose(HG),HG plus CTRP3 group(HG+CT),HG plus CTRP3 treatment plus siRNA transfection group(HG+CT+siRNA),HG plus CTRP3 treatment plus Sirt1 siRNA transfection group(HG+CT+siSirt1).Cholesterol content and efflux levels in different groups were detected using cholesterol detection kits according to instructions of the manufacturer,and cholesterol accumulation was detected by Filipin staining.The activity of Sirt1 enzyme was measured using commercial detection kit.Western blot was used to detect the protein expression of CTRP3,Sirt1,LXRα,and ABCA1 in HK-2 cells.The level of CTRP3 mRNA was detected by Real-time PCR.Recombinant protein CTRP3 treatment significantly inhibited the HG-induced cholesterol accumulation and promoted the level of cholesterol efflux in HK-2 cells.In addition,down-regulation of CTRP3,Sirt1,LXRα,and ABCA1 protein expression and Sirt1 activity induced by HG were markedly prevented by treatment with recombinant protein CTRP3.After the application of Sirt1 siRNA to inhibit the expression of Sirt1,the above regulatory effects of CTRP3 on HK-2 cells disappeared.These findings indicated that CTRP3 had protective effects on HG-induced cholesterol accumulation in HK-2 cells.The mechanism of role performed by CTRP3 may include,at least in part regulating the expression of Sirt1 and promoting the cholesterol efflux.
作者 梁子辉 朱艳 任韫卓 吴明 韩伟霞 张国宇 胡越 杜春阳 LIANG Zihui;ZHU Yan;REN Yunzhuo;WU Ming;HAN Weixia;ZHANG Guoyu;HU Yue;DU Chunyang(Hebei Medical University,Department of General Theory of surgery and Surgical Science,Shijiangzhuang,050017,China;Hebei Medical University,Department of Electron Microscope,Shijiazhuang,050017,China;Hebei Medical University,Department of Pathology,Shijiazhuang 050017,China)
出处 《中国细胞生物学学报》 CAS CSCD 2019年第11期2108-2115,共8页 Chinese Journal of Cell Biology
基金 河北省教育厅重点研发计划项目(批准号:ZD2018007) 河北省重点研发计划项目(批准号:18277748D) 河北医科大学大学生创新实验项目(批准号:USIP2018183、USIP2018151)资助的课题.
关键词 C1q/肿瘤坏死因子相关蛋白3 沉默信息调节因子2相关酶1 胆固醇 肾小管细胞 高糖 CTRP3 Sirt1 cholesterol renal tubular cells high glucose
作者简介 通讯作者:杜春阳,Tel:0311-86265724,E-mail:duchunyang55@163.com
  • 相关文献

参考文献2

二级参考文献16

  • 1Nangaku M. Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17(1): 17-25.
  • 2Devarajan P. Update on mechanisms of ischemic acute kidney injury. JAm SocNephrol 2006; 17(6): 1503-20.
  • 3Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, et al. SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol 2011; 301(2): F427-35.
  • 4Liang J, Tian S, Han J, Xiong P. Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction. Ren Fail 2014; 36(2): 285-91.
  • 5Li J, Qu X, Ricardo SD, Bertram JF, Nikolic-Paterson DJ. Resveratrol inhibits renal fibrosis in the obstructed kidney: Potential role in deacetylation of Smad3. Am J Pathol 2010; 177(3): 1065-71.
  • 6Huang XZ, Wen D, Zhang M, Xie Q, Ma L, Guan Y, et al. SIRT1 activation ameliorates renal fibrosis by inhibiting the TGF-beta/ Smad3 pathway. J Cell Biochem 2014; 115(5): 996-1005.
  • 7Ni J, Shen Y, Wang Z, Shao DC, Liu J, Fu LJ, et al. Inhibition of STAT3 acetylation is associated with angiotesin renal fibrosis in the obstructed kidney. Acta Pharmacol Sin 2014; 35(8):1045-54.
  • 8Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007; 450(7170): 712-6.
  • 9Schimizu H, Maruyama S, Yuzawa Y, Kato T, Miki Y, Suzuki S, et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuated renal injury induced by protein-overload proteinuria. J Am Soc Nephrol 2002; 14(6): 1496-1505.
  • 10Bitzer M, Sterzel RB, B6ttinger EP. Transforming growth factor- beta in renal disease. Kidney Blood Press Res 1998; 21(1): 1-12.

共引文献9

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部